| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |